The FDA Simply Rejected a Bid for MDMA’s Approval to Deal with PTSD

The company has requested drugmaker Lykos Therapeutics to run an extra research on the usage of the psychedelic drug in sufferers with post-traumatic stress dysfunction, pushing again its subsequent proposal by years.